INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

73,606 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SJ
Seehra JasbirDirector, CHIEF EXECUTIVE OFFICER
KROSKeros Therapeutics, Inc.
Grant or award
A—
62.5K sh
Jan 7, 2026Jan 9, 2026
Page 1537 of 1841
← PrevNext →
traded Jan 7, 2026
+2d
SEC Form 4

Evidence

9
PL
Pawlak Chad Lee Sr.Director, Chief Executive Officer, 10% Owner
GNVRGenvor Inc
Grant or award
A—
250.0K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

9
BS
Billings Craig ScottDirector, CEO
WYNNWYNN RESORTS LTD
Grant or award
A—
14.1K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
DC
Doster Travis C.CHIEF COMMUNICATIONS OFFICER
TXRHTexas Roadhouse, Inc.
Grant or award
A—
2,700 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
SW
Smart Justin WilliamPresident
NYSEKRCKILROY REALTY CORP
Tax withholding
F$44K
1,124 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
PA
Paradise AndrewDirector, Chief Executive Officer, 10% Owner
SKLZFiry Inc.
Option exercise
M—
23.8K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
SS
Schwartz Sherrie SageSee Remarks
NYSEKRCKILROY REALTY CORP
Grant or award
A—
38 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
TA
Tobin Regina A.PRESIDENT
TXRHTexas Roadhouse, Inc.
Grant or award
A—
4,200 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
PA
Paradise AndrewDirector, Chief Executive Officer, 10% Owner
SKLZFiry Inc.
Tax withholding
F$26K
5,798 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
BI
Bruns IngmarChief Medical Officer
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A—
365.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
MK
McLaughlin KirkDirector
NBHCNational Bank Holdings Corp
Grant or award
A—
3,530 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$369K
2,448 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
PA
Paradise AndrewDirector, Chief Executive Officer, 10% Owner
SKLZFiry Inc.
Tax withholding
F$42K
9,370 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
CS
Connelly StephenDirector, President and CSO
EQEquillium, Inc.
Grant or award
A—
1.15M sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
CA
Crawford Michael AnthonyDirector
TXRHTexas Roadhouse, Inc.
Grant or award
A—
1,200 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
MK
McLaughlin KirkDirector
NBHCNational Bank Holdings Corp
Grant or award
A—
378.0K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
FG
Franceschi GaetanoChief Financial Officer
SKLZFiry Inc.
Option exercise
M—
19.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
TE
Trencher EliottEVP, Chief Investment Officer
NYSEKRCKILROY REALTY CORP
Grant or award
A—
279 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
AG
Abell Jane GroteDirector
TXRHTexas Roadhouse, Inc.
Grant or award
A—
1,200 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
CA
Crawford Michael AnthonyDirector
TXRHTexas Roadhouse, Inc.
Option exercise
M—
1,200 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
PR
Paratte A. RobertSee Remarks
NYSEKRCKILROY REALTY CORP
Grant or award
A—
417 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
SB
Stoneberg Peter B.Director
NYSEKRCKILROY REALTY CORP
Grant or award
A—
312 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
ML
Mastrocola LaurenPrincipal Accounting Officer
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$10K
35 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
SJ
Steinmetz JohnExec Mng Dir of Strategic Init
NBHCNational Bank Holdings Corp
Grant or award
A—
442.1K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
AM
Aman Angela MDirector, Chief Executive Officer
NYSEKRCKILROY REALTY CORP
Grant or award
A—
501 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
DC
Doster Travis C.CHIEF COMMUNICATIONS OFFICER
TXRHTexas Roadhouse, Inc.
Grant or award
A—
9,400 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
AG
Abell Jane GroteDirector
TXRHTexas Roadhouse, Inc.
Option exercise
M—
1,200 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

9
KJ
Krum JacquiEVP and General Counsel
WYNNWYNN RESORTS LTD
Grant or award
A—
1,915 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
CS
Carroll Patrick SPres., Environmental Solutions
TEXTEREX CORP
Grant or award
A$2,312
40 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

9
GF
Gladbach EDWIN FSVP, GC AND SECRETARY
AMCAMC ENTERTAINMENT HOLDINGS, INC.
Derivative conversion
C—
880 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

8
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$185K
4,421 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
15.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

8
RM
Richard MarkPresident - Western Hemisphere
HALHALLIBURTON CO
Tax withholding
F$221K
7,469 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

7
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$726K
17.5K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

7
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$908K
47.2K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$212K
1,417 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$160K
1,050 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$146K
950 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

6
RM
Reaume Marty MDirector
SPSCSPS COMMERCE INC
Option exercise · 10b5-1 plan
M$90K
1,732 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$190K
1,250 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence